• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Disulfide- and terminal alkyne-functionalized magnetic silica particles for enrichment of azido glycopeptides?
  Sheng Wang,Wenxian Xie,Xiu Zhang,Xia Zou,Yan Zhang Chem. Commun., 2012,48, 5907-5909
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

Introduction to 1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxohexacosyl)oxy]-, inner salt, (2R) and Its Significance in Modern Chemical Research

The compound with the CAS number 2260670-67-3, identified as 1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxohexacosyl)oxy]-, inner salt, (2R), represents a fascinating subject of study in the realm of chemical biology and pharmaceutical innovation. This intricate molecule, characterized by its unique structural composition and functional groups, has garnered attention due to its potential applications in drug development and biochemical research. The presence of a chiral center at the (2R) configuration adds an additional layer of complexity, making it a valuable candidate for exploring stereoselective synthesis and biological activity.

At the core of this compound's structure lies a quaternary ammonium salt, which is stabilized by an inner salt formation. This stability is critical for its utility in various chemical reactions and biological assays. The carboxylic acid group at the 3-position provides a site for further functionalization, enabling the attachment of diverse biomolecules or pharmacophores. Moreover, the incorporation of deuterated methyl groups (N,N,N-tri(methyl-d3)) enhances the compound's suitability for NMR spectroscopic studies, facilitating detailed structural elucidation and dynamic analysis.

The long aliphatic chain attached to the oxygen atom via an ether linkage (1-oxohexacosyl)oxy-) introduces hydrophobicity to the molecule, influencing its solubility and interaction with biological membranes. This feature is particularly relevant in drug design, where membrane permeability and binding affinity are crucial parameters. The hexacosyl chain, with its 26 carbon atoms, imparts a substantial molecular weight, which can be advantageous in certain pharmacological contexts where larger molecules exhibit improved target engagement or reduced metabolism.

Recent advancements in chemical synthesis have enabled the efficient preparation of such complex molecules. Techniques such as solid-phase peptide synthesis (SPPS) combined with transition-metal-catalyzed coupling reactions have been instrumental in constructing the intricate framework of this compound. These methodologies not only improve yield but also enhance purity, which is essential for subsequent biological evaluations. The ability to produce enantiomerically pure forms of chiral compounds like this one has opened new avenues in pharmacology, particularly in the development of single-enantiomer drugs that exhibit reduced side effects.

In the realm of biochemical research, 1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxohexacosyl)oxy]-, inner salt, (2R) has been explored for its potential interactions with biological targets. The quaternary ammonium core is known to interact with various enzymes and receptors due to its positive charge and lipophilic nature. Studies have suggested that such compounds may serve as probes or inhibitors in pathways involving acetylcholinesterase or other esterases. The deuterated methyl groups can also be exploited to study metabolic pathways through deuterium labeling techniques.

The long aliphatic chain mimics fatty acid residues found in natural biomolecules, suggesting potential applications in modulating lipid-mediated signaling pathways. For instance, derivatives of this compound could be designed to interfere with cholesterol biosynthesis or modify membrane fluidity. Such modifications are of significant interest in the fight against cardiovascular diseases and neurodegenerative disorders where lipid metabolism plays a pivotal role.

Furthermore, the chiral center at the (2R) configuration allows for stereochemical control over biological activity. Enantiomers often exhibit markedly different pharmacological profiles due to their distinct interactions with biological receptors. By synthesizing and evaluating both enantiomers of this compound, researchers can gain insights into the importance of stereochemistry in drug design. This approach has been particularly successful in developing antiviral agents where enantiomeric purity is critical for efficacy.

The integration of mass spectrometry (MS), nuclear magnetic resonance (NMR), and X-ray crystallography has provided comprehensive structural characterization of this compound. These techniques not only confirm molecular connectivity but also reveal conformational dynamics and binding interactions. For instance, NMR studies have been instrumental in understanding how the deuterated methyl groups influence molecular rotation rates within different solvent environments.

In conclusion,1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxohexacosyl)oxy]-, inner salt, (2R) represents a promising entity in chemical biology and pharmaceutical research. Its unique structural features—ranging from the quaternary ammonium core to the long aliphatic chain—offer diverse opportunities for functionalization and application. As synthetic methodologies continue to evolve and our understanding of biological pathways deepens,CAS number 2260670-67-3 will undoubtedly play a pivotal role in shaping future therapeutic strategies.

• 1976-27-8(1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxooctadecyl)oxy]-, inner salt)
• 102636-82-8(Glutaroyl carnitine)
• 155309-04-9(1-Butanaminium,N,N,N-trimethyl-4-(1-methylethoxy)-4-oxo-2-[(1-oxohexadecyl)oxy]-)
• 142759-00-0(1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxoundecyl)oxy]-, inner salt)
• 25243-95-2(1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxooctyl)oxy]-, inner salt, (2R)-)
• 1492-27-9(1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxodecyl)oxy]-, inner salt)
• 142674-35-9(1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxotridecyl)oxy]-, inner salt)
• 119766-69-7(1-Propanaminium,3-carboxy-N,N-dimethyl-N-(methyl-d3)-2-[(1-oxodecyl)oxy]-, inner salt (9CI))
• 22671-29-0(L-Hexanoylcarnitine)
• 1935-18-8(1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, inner salt)